The expression of tumor BATF and glucose transporter 1 (GLUT-1) were examined using immunohistochemical tools in 37 CRC patients undergoing preoperative <sup>18</sup>F-FDG PET/CT imaging. The gene discussed is SLC2A1; the disease is neoplasm.